1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Advanced Prostate Cancer: new trials by email Literature Review of Advanced Prostate Cancer trials Research Report on Advanced Prostate Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nivolumab With or Without Ipilimumab in Advanced Metastatic Cancer Nivolumab Monotherapy, Nivolumab and Ipilimumab and Combination for Metastatic Cancer, Nivolumab and Ipilimumab (3 mg/kg) Combination for Prostate Cancer - Advanced Metastatic Cancer, Advanced Prostate Cancer | Phase 2 | Completed | Parker Institute for Cancer Immunotherapy | 100 | 2018-10-17 | 2024-02-07 |
Ipilimumab (1) · Nivolumab (1)
Parker Institute for Cancer Immunotherapy (1)
United States (1)